Researchers in the molecular pharmacology group utilise genomic, biophysical, biochemical and stem-cell technologies to identify disease processes and novel druggable targets for development of treatments for human disease. Our studies include modulation of post translational modification of cardiovascular disease proteins and determinants of vascular remodelling and repair.
Fernandez Caggiano GroupCardiac metabolism and the mitochondrial pyruvate carrier's role in heart disease.
Campanella Group Mitochondrial Cell Biology and Pharmacology Research.
Carvalho GroupNeuropsychology, Inflammation and cognitive function.
Charles GroupRedox sensing and signalling in cardiovascular and pulmonary systems.
Eaton GroupRedox signalling in cardiovascular health and disease.
Tinker GroupCardiac arrhythmia and the role of ion channels in cardiac and vascular excitability.
Xiao GroupStem cells and Cardiovascular disease.
Xu GroupStem/progenitor cells in arteriosclerosis.